INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 441m ago
HOUSE PTR41m ago
SEC 13F41m ago
ROBINHOOD CHAIN41m ago
Corporate insider
WA

Williams Laura A

Chief Patient OfficerCIK 0001869194

EDGAR filingsOpen in network
Disclosed transactions10
Buys / sells0 / 6
Max Insider Score32
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
32
WA
Williams Laura AChief Patient Officer
ARDXARDELYX, INC.
Open-market sale
SELL$9,372
2,430 sh
Aug 21, 2026Aug 25, 2026
traded Aug 21, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    ARDELYX, INC.Chief Patient Officer · Jan 9, 2026
32
WA
Williams Laura AChief Patient Officer
ARDXARDELYX, INC.
Open-market sale
SELL
$6,688
1,734 sh
Aug 21, 2026
Aug 25, 2026
traded Aug 21, 2026
+4d
SEC FORM 4

Evidence

32
WA
Williams Laura AChief Patient Officer
ARDXARDELYX, INC.
Open-market sale
SELL$13K
3,486 sh
Aug 21, 2026Aug 25, 2026
traded Aug 21, 2026
+4dSEC FORM 4

Evidence

32
WA
Williams Laura AChief Patient Officer
ARDXARDELYX, INC.
Open-market sale
SELL$12K
3,089 sh
Aug 21, 2026Aug 25, 2026
traded Aug 21, 2026
+4dSEC FORM 4

Evidence

0
WA
Williams Laura AChief Patient Officer
ARDXARDELYX, INC.
Option exercise · 10b5-1 plan
M$31K
31.0K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC FORM 4

Evidence

11
WA
Williams Laura AChief Patient Officer
ARDXARDELYX, INC.
Open-market sale · 10b5-1 plan
SELL$490K
81.9K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC FORM 4

Evidence

0
WA
Williams Laura AChief Patient Officer
ARDXARDELYX, INC.
Option exercise · 10b5-1 plan
M—
31.0K sh
Jun 18, 2026Jun 22, 2026
traded Jun 18, 2026
+4dSEC FORM 4

Evidence

0
WA
Williams Laura AChief Patient Officer
ARDXARDELYX, INC.
Option exercise · 10b5-1 plan
M—
0 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC FORM 4

Evidence

3
WA
Williams Laura AChief Patient Officer
ARDXARDELYX, INC.
Option exercise · 10b5-1 plan
M$50K
50.0K sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC FORM 4

Evidence

15
WA
Williams Laura AChief Patient Officer
ARDXARDELYX, INC.
Open-market sale · 10b5-1 plan
SELL$349K
50.0K sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC FORM 4

Evidence